Medpace Holdings, Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

653.11

+18.13 (2.86%)

At close: Nov 6, 2026, 4:00 PM EST

658.88

+5.77 (0.88%)

After-hours: Nov 6, 2026, 7:49 PM EST

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Metabolic Revenue	915.68M	744.96M	457.54M
Oncology Revenue	836.45M	747.59M	651.24M
Other Sources of Revenue	379.80M	408.55M	431.38M
Central Nervous System Revenue	319.90M	254.84M	181.98M
Cardiology Revenue	240.69M	239.37M	230.45M
AVAI Revenue	145.86M	134.94M	156.46M
Revenue (Total)	2.84B	2.53B	2.11B

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Net New Business Awards	3.02B	2.65B	2.23B
Total Backlog	3.17B	3.03B	2.90B
Book-to-Bill Ratio	-	1.05	1.06